Ruth Geva

Title: Ruth Geva: Innovator in Pharmaceutical Compositions

Introduction

Ruth Geva is a notable inventor based in Jerusalem, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for various types of cancer. Her innovative work has the potential to impact the lives of many patients suffering from serious health conditions.

Latest Patents

Ruth Geva holds a patent for "Verotoxin pharmaceutical compositions and medical treatments therewith." This patent involves pharmaceutical compositions that comprise known verotoxins, specifically verotoxin 1 and its pentameric subunit B. These compositions have been found to be useful in treating mammalian neoplasia, including brain cancer, ovarian cancer, breast cancer, and skin cancer. Although verotoxin 1 has previously demonstrated anti-neoplastic activity in vitro, non-lethal doses have shown therapeutic anti-neoplastic effects in vivo. The use of a sensitizer, such as sodium butyrate, enhances the efficacy of verotoxins and their subunit B.

Career Highlights

Throughout her career, Ruth Geva has focused on advancing medical treatments through innovative pharmaceutical compositions. Her research has contributed to a deeper understanding of how verotoxins can be utilized in cancer therapy. With her patent, she has positioned herself as a key player in the pharmaceutical industry.

Collaborations

Ruth Geva has collaborated with esteemed colleagues, including Clifford A Lingwood and Richard C Hill. These partnerships have allowed her to enhance her research and expand the impact of her work in the field of pharmaceuticals.

Conclusion

Ruth Geva's contributions to pharmaceutical innovations, particularly in cancer treatment, highlight her role as a pioneering inventor. Her patent on verotoxin compositions represents a significant advancement in medical science. The potential applications of her work could lead to improved therapies for patients facing serious health challenges.